{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:26:49Z","timestamp":1792722409216,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijrobp.2021.11.027","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T17:56:14Z","timestamp":1638726974000},"page":"40-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC)"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-2692","authenticated-orcid":false,"given":"Katherine","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tue","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard G.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Dammak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Yeghiaian-Alvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.11.027_bib0001","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2011.12.018","article-title":"Radiographic changes after lung stereotactic ablative radiotherapy (SABR)\u2014can we distinguish recurrence from fibrosis? A systematic review of the literature","volume":"102","author":"Huang","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jtho.2019.10.016","article-title":"Salvage therapy for locoregional recurrence after stereotactic ablative radiotherapy for early-stage NSCLC","volume":"15","author":"Brooks","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0004","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"5 Suppl","key":"10.1016\/j.ijrobp.2021.11.027_bib0005","doi-asserted-by":"crossref","first-page":"e437S","DOI":"10.1378\/chest.12-2365","article-title":"Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Colt","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0006","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/annonc\/mdu089","article-title":"2nd ESMO consensus conference on lung cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up","volume":"25","author":"Vansteenkiste","year":"2014","journal-title":"Annal Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0007","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.prro.2017.10.008","article-title":"Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi consensus study","volume":"8","author":"Nguyen","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41747-018-0068-z","article-title":"Radiomics: The facts and the challenges of image analysis","volume":"2","author":"Rizzo","year":"2018","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0009","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0010","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0011","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/0284186X.2012.731525","article-title":"Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes","volume":"52","author":"Mattonen","year":"2013","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0012","doi-asserted-by":"crossref","DOI":"10.1118\/1.4866219","article-title":"Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer","volume":"41","author":"Mattonen","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0013","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijrobp.2006.05.008","article-title":"CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers?","volume":"66","author":"Kimura","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0014","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/1759-7714.12162","article-title":"Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis","volume":"6","author":"Hayashi","year":"2015","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.21037\/tlcr-20-609","article-title":"The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer","volume":"9","author":"Li","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0016","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10147-007-0691-9","article-title":"Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors","volume":"12","author":"Matsuo","year":"2007","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2009.09.006","article-title":"Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT)","volume":"69","author":"Trovo","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0018","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2214\/ajr.150.4.765","article-title":"CT appearance of acute radiation-induced injury in the lung","volume":"150","author":"Ikezoe","year":"1988","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0019","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2214\/ajr.178.6.1781383","article-title":"Radiation injury of the lung after three-dimensional conformal radiation therapy","volume":"178","author":"Koenig","year":"2002","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ijrobp.2012.01.088","article-title":"Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer","volume":"84","author":"Dunlap","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0021","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2007.07.2383","article-title":"Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer","volume":"70","author":"Takeda","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0022","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2012.11.008","article-title":"Evaluation for local failure by 18F-FDG PET\/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer","volume":"79","author":"Takeda","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11604-009-0415-3","article-title":"Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma","volume":"28","author":"Kato","year":"2010","journal-title":"Jpn J Radiol"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2021.11.027_bib0024","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.21037\/tlcr.2017.10.01","article-title":"Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC)","volume":"6","author":"Frakulli","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clinimag.2014.12.005","article-title":"Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy","volume":"39","author":"Halpenny","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2013.06.047","article-title":"High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer","volume":"109","author":"Huang","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0027","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2016.04.003","article-title":"Validation of high-risk computed tomography features for detection of local recurrence after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"96","author":"Peulen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0028","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cllc.2015.12.003","article-title":"The fate of residual tumor masses that persist after stereotactic body radiotherapy for solitary lung nodules: Will they recur?","volume":"17","author":"Takenaka","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0029","first-page":"121","article-title":"Early PET-CT after stereotactic radiotherapy for stage 1 non-small cell lung carcinoma is predictive of local control","volume":"32","author":"Tyran","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLC.2008.n.032","article-title":"Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: The role of positron emission tomography\/computed tomography\u2013based treatment planning","volume":"9","author":"Coon","year":"2008","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0031","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00066-013-0310-9","article-title":"Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy","volume":"189","author":"Essler","year":"2013","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0032","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-3-6","article-title":"CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography\/computed tomography serial tumor response assessment","volume":"3","author":"Vahdat","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0033","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijrobp.2011.10.035","article-title":"Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer","volume":"83","author":"Zhang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0034","first-page":"1836","article-title":"SUV: Standard uptake or silly useless value?","volume":"36","author":"Keyes","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.13-2281","article-title":"Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer","volume":"146","author":"Pastis","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0036","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejrad.2017.04.022","article-title":"Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study","volume":"92","author":"Shintani","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0037","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijrobp.2009.02.051","article-title":"A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy","volume":"76","author":"Henderson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0038","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2011.03.003","article-title":"Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors","volume":"99","author":"Mohammed","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0039","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2006.12.009","article-title":"FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer","volume":"56","author":"Hoopes","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12149-012-0682-4","article-title":"Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: Characterization of 18F-FDG PET\/CT findings","volume":"27","author":"Nakajima","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0041","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1002\/cam4.3302","article-title":"Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy","volume":"9","author":"Tan","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0042","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/j.ijrobp.2012.01.012","article-title":"Residual (1)(8)F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control","volume":"83","author":"Bollineni","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0043","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0044","doi-asserted-by":"crossref","first-page":"46349","DOI":"10.1038\/srep46349","article-title":"Radiomics-based prognosis analysis for non-small cell lung cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0045","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1002\/mp.12309","article-title":"Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"44","author":"Li","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0046","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13014-017-0892-y","article-title":"CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy","volume":"12","author":"Li","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0047","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/RCT.0000000000000262","article-title":"Computed tomography assessment of ablation zone enhancement in patients with early-stage lung cancer after stereotactic ablative radiotherapy","volume":"39","author":"Moore","year":"2015","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108978","article-title":"Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis","volume":"127","author":"Kim","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0049","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijrobp.2017.09.035","article-title":"Incidence of high-risk radiologic features in patients without local recurrence after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer","volume":"100","author":"Ronden","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2021.11.027_bib0050","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.2967\/jnumed.108.057182","article-title":"Standards for PET image acquisition and quantitative data analysis","volume":"50","author":"Boellaard","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0051","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","article-title":"EANM\/EARL harmonization strategies in PET quantification: From daily practice to multicentre oncological studies","volume":"44","author":"Aide","year":"2017","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0052","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0053","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0054","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.radonc.2020.10.023","article-title":"A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy","volume":"155","author":"Kothari","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2015.12.369","article-title":"Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: Physician performance versus radiomic assessment","volume":"94","author":"Mattonen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0056","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.tranon.2019.02.005","article-title":"Diffusion-weighted magnetic resonance imaging is useful for the response evaluation of chemotherapy and\/or radiotherapy to recurrent lesions of lung cancer","volume":"12","author":"Usuda","year":"2019","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0057","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijrobp.2019.06.2536","article-title":"Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: A prospective clinical trial","volume":"105","author":"Sampath","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0058","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clon.2010.11.009","article-title":"Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: Pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomography","volume":"23","author":"Dahele","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.11.027_bib0059","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/MNM.0b013e3283512b08","article-title":"The role of positron emission tomography following radiosurgical treatment of malignant lung lesions","volume":"33","author":"Gill","year":"2012","journal-title":"Nucl Med Commun"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621032351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621032351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:58:46Z","timestamp":1759744726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621032351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0360301621032351"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}